Wilkerson Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Wilkerson Advisory Group's LLY Position: Q2 2026 in Review
Wilkerson Advisory Group increased its Eli Lilly (LLY) stake by 0.62% in Q2 2026, buying an estimated $9.2K and bringing the position to 1,463 shares worth $1.75M. The position accounts for 0.54% of the portfolio, ranked #30.
Wilkerson Advisory Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Wilkerson Advisory Group held 1,463 shares of Eli Lilly worth $1.75M as of Q2 2026.
- Wilkerson Advisory Group bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
- Eli Lilly made up 0.54% of Wilkerson Advisory Group's portfolio in Q2 2026, its #30 holding.
- Wilkerson Advisory Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Wilkerson Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.